中财网 中财网股票行情
拓新药业(301089)财务分析指标    年份：
截止日期2025-12-312025-09-302025-06-302025-03-312024-12-31
营业总收入(万元)37834.3627155.3618189.989699.4742169.41
营业收入(万元)37834.3627155.3618189.989699.4742169.41
营业总成本(万元)46308.1131578.3320228.3710416.7645944.10
营业成本(万元)27854.7019182.2012512.676725.8429574.66
净利润(万元)-6834.34-3016.11-1828.05-356.47-1911.57
归属于母公司的净利润(万元)-6966.10-3016.11-1828.05-356.47-1988.49
营业利润(万元)-7175.75-3635.82-2105.58-373.45-2371.82
利润总额(万元)-7238.54-3650.96-2143.13-396.83-2773.25
少数股东损益(万元)----------
基本每股收益(元)-0.55(元)-0.24(元)-0.14(元)-0.03(元)-0.16(元)
稀释每股收益(元)-0.55(元)-0.24(元)-0.14(元)-0.03(元)-0.16(元)
非经常性损益(万元)--578.18--238.79737.05
扣除非经常性损益后净利润(万元)-7893.81-3594.28-2220.76-595.27-2725.54
总资产(万元)166529.64168936.52170723.00175169.37175824.39
总负债(万元)18111.9716700.6217299.0520273.8420572.39
归属于母公司股东权益合计(万元)148417.67152235.90153423.95154895.53155252.01
股东权益合计(万元)148417.67152235.90153423.95154895.53155252.01
实收资本(股本)(万元)12654.4512654.4512654.4512654.4512654.45
资本公积(万元)62111.0062111.0062111.0062111.0062111.00
未分配利润(万元)66777.2170727.2071915.2673386.8473743.31
经营活动产生的现金流量净额(万元)-2618.69-2278.96-2301.46-2801.0510266.87
经营活动现金流入小计(万元)31023.8124574.2016104.687406.3641806.99
经营活动现金流出小计(万元)33642.5026853.1618406.1410207.4231540.12
投资活动产生的现金流量净额(万元)7054.062434.031898.1211124.24-13987.61
投资活动现金流入小计(万元)98499.5572891.1647257.8834188.7361403.62
投资活动现金流出小计(万元)91445.4970457.1345359.7623064.4975391.23
筹资活动产生的现金流量净额(万元)-121.00-122.42-----3257.29
筹资活动现金流入小计(万元)1.42--------
筹资活动现金流出小计(万元)122.42122.42----3257.29
期末现金及现金等价物余额(万元)10463.756195.395787.9914519.726178.17
最后修改日期2026-03-282025-10-292025-08-272025-04-292025-04-29
↑返回页顶↑

转至拓新药业（301089）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。